OverviewSuggest Edit

Photocure, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products and related technical medical equipment. The Company offers Hexvix/Cysview for the detection and management of bladder cancer. It is also developing Visonac that has completed Phase IIb study for the treatment of moderate to severe acne; and Cevira, which has completed Phase IIb study for the treatment of human papilloma virus infection and precancerous lesions of the cervix.

TypePublic
Founded1997
HQUllern, NO
Websitephotocure.com

Latest Updates

Employees (est.) (Dec 2020)100(+50%)
Share Price (Jan 2021)KR105.4 (+4%)
Cybersecurity ratingAMore

Key People/Management at Photocure

Daniel Schneider

Daniel Schneider

President and Chief Executive Officer
Johanna Holldack

Johanna Holldack

Director
Erik Dahl

Erik Dahl

Chief Financial Officer
Geoffrey Coy

Geoffrey Coy

Vice President and General Manager of U.S. Operations
Anders Tuv

Anders Tuv

Director
Anne Worsøe

Anne Worsøe

Director
Show more

Photocure Office Locations

Photocure has offices in Ullern and Princeton
Ullern, NO (HQ)
4 Hoffsveien
Princeton, NJ, US
104 Carnegie Center Dr #303
Show all (2)

Photocure Financials and Metrics

Photocure Revenue

Market capitalization (19-Jan-2021)

2.8b

Closing stock price (19-Jan-2021)

105.4
Photocure's current market capitalization is kr2.8 b.
Show all financial metrics

Photocure Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

Photocure Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

30-39

out of 100

CSRHub logo

Photocure Online and Social Media Presence

Embed Graph

Photocure News and Updates

Photocure ASA: Results for the third quarter of 2020

OSLO, Norway, Nov. 10, 2020 /PRNewswire/ -- Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 49.6 million in the third quarter of 2020 (Q3 2019: NOK 51.1), with the U.S. market continuing the COVID-19 rebound with a growth of 20%. Photocure has successfully launched...

Photocure announces new Cevira patent in Europe

OSLO, Norway, Oct. 5, 2020 /PRNewswire/ -- Photocure ASA (OSE:PHO) today announces that the European Patent Office (EPO) has granted patent EP 2983780 covering the commercial Cevira® device in Europe until 2034. Cevira is a photodynamic drug-device combination product under development...

Photocure launches European Hexvix operations

OSLO, Norway, Oct. 1, 2020 /PRNewswire/ -- Photocure ASA (OSE:PHO) today announces the commencement of the sales, marketing and distribution of Hexvix® in the European markets formerly operated by Ipsen Pharma SAS (Ipsen). The successful transition and launch of European Hexvix operations...

Photocure ASA: Results for the second quarter and first half of 2020

OSLO, Norway, Aug. 18, 2020 /PRNewswire/ -- Photocure ASA (OSE:PHO) reported Hexvix®/Cysview® revenues of 53.5 million in the second quarter of 2020 (Q2 2019: NOK 52.1), corresponding to growth of three per cent, despite a significant Covid-19 impact in the beginning of the quarter in the...

Photocure appoints Genotests as exclusive partner for Hexvix in Chile

OSLO, Norway, Aug. 13, 2020 /PRNewswire/ -- Photocure ASA (OSE: PHO), today announced the appointment of Genotests SpA as the exclusive distributor for the commercialization of Hexvix® in Chile. "We are proud to take our first step into the South American continent and make Hexvix...

Photocure Appoints Susanne Strauss as Vice President and General Manager of Europe

OSLO, Norway, July 1, 2020 /PRNewswire/ -- Photocure ASA (OSE:PHO), today announced the appointment of Susanne Strauss as Vice President and General Manager of Europe, effective 1 July 2020. "I am pleased to welcome Susanne Strauss to the Photocure team and I am confident that Susanne's...
Show more

Photocure Frequently Asked Questions

  • When was Photocure founded?

    Photocure was founded in 1997.

  • Who are Photocure key executives?

    Photocure's key executives are Daniel Schneider, Johanna Holldack and Erik Dahl.

  • How many employees does Photocure have?

    Photocure has 100 employees.

  • Who are Photocure competitors?

    Competitors of Photocure include Medline Industries, Medexus Pharma and Vascular BioSciences.

  • Where is Photocure headquarters?

    Photocure headquarters is located at 4 Hoffsveien, Ullern.

  • Where are Photocure offices?

    Photocure has offices in Ullern and Princeton.

  • How many offices does Photocure have?

    Photocure has 2 offices.